课题基金 / 基金详情

项目摘要

项目成果

STEPHEN F VATNER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): The current submission is a revised application for our grant on effects of exercise in the receptor of G protein signaling 14 (RGS14) knock out (KO) mouse. The RGS14 KO model, demonstrates enhanced exercise tolerance and energy utilization, resulting not only in longevity, but more significantly, healthful aging. The RGS14 KO reduces beta adrenergic receptor signaling, which might be consistent with longevity, but novel and unexpected as a mechanism for improved exercise, the focus of this application, since enhanced beta adrenergic receptor signaling has always been associated with improved exercise performance. The RGS14 KO model has the additional novel, salutary attribute of increased brown adipose tissue, which is known to increase energy utilization and protect against diabetes, but is not known to mediate enhanced exercise performance, which will be examined in this application. Another key feature of the RGS14 KO is its ability to increase angiogenesis, which would also enhance exercise performance, since limitation of blood flow to exercising muscle causes exercise to cease. The major focus of the current application is to examine the physiological and molecular mechanisms mediating the brown adipose tissue and angiogenesis induced enhanced exercise capacity in the RGS14 KO model. This is important because reduced exercise tolerance is central to all patients with cardiovascular and other diseases, impairing a healthy life style and aging, and conversely enhanced exercise protects against disease and extends longevity. The RGS14 KO also mimics the beneficial features of exercise training. Accordingly, developing an RGS14 inhibitor that can be given to patients would recapitulate the beneficial effects of exercise training without the burden placed on patients to undergo daily exercise. This last point is the focus of Aim C1 in this application.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Pharmacological Inhibitor of Adenylyl Cyclase Type 5 to Treat Alzheimer's Disease
  • 批准号:
    10608477
  • 项目类别:
  • 资助金额:
    $25.21万
  • 财政年份:
    2022
  • 负责人:
    STEPHEN F VATNER
  • 依托单位:
Skeletal Muscle and Brown Adipose Mechanisms Mediating Cardiovascular Risk Factor Protection in RGS14 KO
  • 批准号:
    9900047
  • 项目类别:
  • 资助金额:
    $53.43万
  • 财政年份:
    2017
  • 负责人:
    STEPHEN F VATNER
  • 依托单位:
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk
  • 批准号:
    9900045
  • 项目类别:
  • 资助金额:
    $56.45万
  • 财政年份:
    2017
  • 负责人:
    STEPHEN F VATNER
  • 依托单位:
Vascular Protection in Hibernating Woodchucks
  • 批准号:
    9020511
  • 项目类别:
  • 资助金额:
    $45.47万
  • 财政年份:
    2016
  • 负责人:
    STEPHEN F VATNER
  • 依托单位:
海外基金